۷ι ̿ źźϰ Դ ȯ о߸ Ѿ , ȯ ϰ ־ ߰ ָȴ.
̿ 13 ̿ ۷ι ̵ : ȭϴ コɾ, ȭϴ ̿(Transforming Healthcare, Transforming Bayer) ̿ ӿ, Ʈʻ ǥ 6 ǥڵ ǥ ߴ. ߿ ̷ ̿ ̲ Ұ ̾.
̿ ǥ Factor XI ο 迭 3 ĺ ̸ 2 ӻ ϰ ִ. 汸 FXIa 4,000 ̻ ȯ ǥ 2b ӻ(Phase IIb) ߴ.
̿ ̿Ͻ(IONIS) κ 㰡 ϰ ִ FXIa ü FXI Ƽ øŬƼ(FXI-LICA) ֱ ȯڸ 2 ӻ ߴ. FXI ־ ġ ɼ ȯڿ ġ ɼ ִ.
̿ P2X3 α ٸ ߿ ĺ Ұߴ. ó P2X3 ǰ ȸ ذ ڱó ġ ħ, μ 汤 Űμ ߿ Ѵ.
̿ ο ʱ ϳ ƴ ɼ ִ ϴ ο θ Žϰ, к /Ǵ Ҹ ħ Phase 2b ӻ , ڱó ӻ ۵ ̴. μ 汤 索 Ű漺 Phase 2aܰ ӻ ߴ.
Ӹ ƴ϶ ̿ ټ Ϲͱ ǰ ȯ о߿ ϰ ִ. о߿ ̼ ż (non-metastatic castration-resistant prostate cancer, nmCRPC) ȯڵ ȭ ġ ٷηŸ̵(Darolutamide /» ) ȣ Ÿ ִ.
ش ǰ ̱, ձ(EU), , ij, Ϻ 忡 Ҵ. ̼ ȣ ΰ (metastatic hormone sensitive prostate cancer, mHSPC) ӻ 3 ARASENS 2021 м ̴.
ƮƼ(Larotrectinib) ˷ ȹ NTRK(Neurotrophic Tyrosine Receptor Kinase) ༺, ̼ Ǵ ȯ ɼ , ġ Ǵ ̿ ġ Ҿ ȯڸ ġϱ , ̱ 40 ̻ εǾ. Ư 翡 ù ° ġ.
ܰ迡 ִ dz(Finerenone) ġɼ ̰ 䰡 ִ ȯ(Chronic Kidney Disease) 2 索(Type 2 Diabetes) ȯڵ ̴. ӻ 3 FIDELIO-DKD ̱ Ȱ ٸ ִ.
dz 3 ӻ ȯ 2 索 ȯڵ Ǵ , ̷ ȯ 2 索 α ū Ը 3 ӻ α̴.
ش ӻ ǥġῡ dz ߰ ȿ ϴ 2 Ǿ ִ. ° 3 ӻFIGARO-DKD ȯ 2 索 ȯڵ ӻ ̴.
̱ MSD ñ(Vericiguat) ϵ ɺ(heart failure with reduced ejection fraction, HFrEF) ġḦ ̴. ġδ ߿ ȸϱ Ư Ŀ ִ. 2020 7, ̱ FDA ñ MSD û 켱 ɻ зߴ.
ƿ ̿ ֱ ĭ Ƚ(KaNDy Therapeics) μ ǰ о߿ Ʈ ڻ ߰ ִ. BAY-342(: NT-814) ( ߰ ) ġḦ ȣ 汸 Ű Ű-1,3 2021 3 ȹ̴.
ø(Stefan Oelrich) ̿ ۷ι ̿ ̷ ȭ ӿ Ʈʵ ̳뺣̼ Ʈ Ű ִ. ϸ, 츮 ǥ ȯڵ鿡 ȹ ġḦ ϴ ̸, δ Ƿý Ӱϰ ̶͡ ٿ.
ȣ : | : õ 01577 | : 2022-01-07 | / : ǥ : â | : μ | : Ƽ繫 | ̿ | ȸ | ѹ ̹繫 | | ȸ
.åѰ μ | ǰ | ȭ
| ڹ ν | бȸ
뵿 ǥ â | 뵿 Լöǰ鼭 | ƹ å/ûҳ⺸ȣå : | : sds9988@hanmail.net | ó : 010-8960-3722 : õ ȭ ȭ 230 лû紺 | ȭ | 25δ | Ź | ȭŸ | մ ô | () | νŹ |
ȭü ⰣϺ Ȳ뵿 00001 | 00003 | ǰ鼭 00004()αȸ : 2001 11 17 | ȸ : ӵ
å : 繫 | ̸ : sds9988@hanmail.net | ΰȣ : 214-82-12737
뺯 : | Ѱ : â | å : μ
ּ : ȸ 72 6 ũ 1311 | ǥȭ : 02-782-8808ȣ : | : 04593 | : 2017-07-03 | / : ö
ǥ( ̻) : Ż | :
θ : ڵϹȣ : 670-88-00700 | εϹȣ : 250151-003197
: 152, 819ȣ(, λŸ)
Copyright ()αȸ | Co. Ltd. All rights reserved.뵿||Ȱ|ƹ|ǰ鼭| |Dz|Ȱü|һοմ